Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
8.85
+0.37 (4.36%)
At close: Aug 13, 2025, 4:00 PM
8.84
-0.01 (-0.11%)
After-hours: Aug 13, 2025, 7:04 PM EDT
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
$1,133,107
Profits / Employee
$444,143
Market Cap
1.44B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NVAX News
- 7 days ago - Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Novavax beats quarterly revenue estimates on milestone payment - Reuters
- 7 days ago - Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights - PRNewsWire
- 14 days ago - Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025 - PRNewsWire
- 20 days ago - Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates - Benzinga
- 20 days ago - Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study - PRNewsWire
- 2 months ago - Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study - Reuters